Compare NTAP & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTAP | BDX |
|---|---|---|
| Founded | 1992 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.0B | 54.6B |
| IPO Year | 1996 | 1998 |
| Metric | NTAP | BDX |
|---|---|---|
| Price | $197.87 | $197.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 16 |
| Target Price | ★ $211.69 | $195.57 |
| AVG Volume (30 Days) | ★ 2.1M | 1.4M |
| Earning Date | 12-01-2026 | 11-05-2026 |
| Dividend Yield | 0.95% | ★ 2.12% |
| EPS Growth | ★ 11.99 | N/A |
| EPS | ★ 1.88 | 1.59 |
| Revenue | $6,237,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $18.16 | N/A |
| Revenue Next Year | $5.97 | $2.27 |
| P/E Ratio | ★ $115.78 | $124.49 |
| Revenue Growth | 5.59 | ★ 8.24 |
| 52 Week Low | $93.69 | $140.11 |
| 52 Week High | $240.87 | $213.08 |
| Indicator | NTAP | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 39.96 | 62.99 |
| Support Level | $155.51 | $195.63 |
| Resistance Level | $209.06 | $200.47 |
| Average True Range (ATR) | 8.82 | 3.73 |
| MACD | -2.37 | 0.38 |
| Stochastic Oscillator | 4.50 | 79.54 |
NetApp Inc is storage hardware provider into a software-driven, cloud-centric data infrastructure company. Its flagship ONTAP data management software, together with a comprehensive portfolio of all-flash, hybrid-flash, and cloud-native solutions, forms the backbone of digital transformation for thousands of enterprises world'wide. Its operations are organized into two segments Hybrid Cloud and Public Cloud. It generates majority of revenue from Hybrid Cloud offers a unified data storage portfolio of storage management and infrastructure solutions that helps customers modernize their data centers. Hybrid Cloud includes software, hardware, and related support, along with professional and other services. It generates majority of revenue from United States followed by International market.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.